Related references
Note: Only part of the references are listed.In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice
Meihua Jin et al.
DRUG DELIVERY (2013)
Management of recurrent cervical cancer: A review of the literature
M. Peiretti et al.
SURGICAL ONCOLOGY-OXFORD (2012)
The imbalance of Th17/Treg in patients with uterine cervical cancer
Yan Zhang et al.
CLINICA CHIMICA ACTA (2011)
The Effects of Artesunate on the Expression of EGFR and ABCG2 in A549 Human Lung Cancer Cells and a Xenograft Model
Hu Ma et al.
MOLECULES (2011)
Immunotherapy for Cervical Cancer Research Status and Clinical Potential
Jun-Han Su et al.
BIODRUGS (2010)
High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells
Michael Herfs et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer
Christoph Loddenkemper et al.
CANCER SCIENCE (2009)
Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells
Jung-Min Oh et al.
CARCINOGENESIS (2009)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
Host immune responses to cervical cancer
Swati Patel et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2009)
Progress in Research on the Anti-tumor Effect of Artesunate
He Rong-rong et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2008)
Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein high, Foxp3-expressing CD25+ and CD25- regulatory T cells
Masahiro Ono et al.
JOURNAL OF IMMUNOLOGY (2006)
Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo
GL Disbrow et al.
CANCER RESEARCH (2005)
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells
F Baratelli et al.
JOURNAL OF IMMUNOLOGY (2005)
Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancer
VR Holla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate
R Dell'Eva et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro
HH Chen et al.
PHARMACOLOGICAL RESEARCH (2003)
Share Paper
